video

sound

Persian Version

View:

300

Download:

156

Cites:

Information Journal Paper

Title

CEREBRAL VENOUS SINUS THROMBOSIS FOLLOWING SILDENAFIL ADMINISTRATION; A CASE REPORT

Writers

AFSHARI D. | MORADIAN N.

Pages

 Start Page 263 | End Page 266

Keywords

PHOSPHODISTERASE TYPE 5 (PDE5) INHIBITORQ3

Abstract

 Background: SILDENAFIL is a selective inhibitor of phosphodiesterase type 5 (PDE5) which currently used for the treatment of ERECTION DYSFUNCTION (ED). Medicine approved by the FDA for treatment of pulmonary hypertension. Although there is no evidence of hyper coagulation states being associated with the use of PDE5 inhibitors, several animal studies suggest that PDE5 inhibitors may cause arterial and venous thrombotic or embolic events. Case report: The patient was a 37 year old man who had suffered sever headache and tonic- clonic generalized seizure. In neurological examination, he had decreased level of consciousness and he had no other positive finding in examination. The patient has been constantly taken 100 mg of SILDENAFIL once a day without medical supervision over the last month. Brain computerized tomography (CT) showed a small hemorrhage in left frontal lobe with suspicious to CEREBRAL VENOUS SINUS THROMBOSIS (CVST) lumbar puncture was performed. Increased cerebrospinal fluid pressure suggested the probability of CVST. Brain MRI result confirmed superior sagittal sinus thrombosis. Conclusion: Cerebral venous sinus thromboses need to be considered a potential side effect of SILDENAFIL administration.

Cites

  • No record.
  • References

  • No record.
  • Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.